Related Experiment Video
Updated: Jan 13, 2026
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Radiotherapy Improves Antitumor Immunity by Inducing Immunogenic Cell Death in Breast Cancer Patients
Ibrahim G Abdelrhman1, Osama O Almesrati2, Sanaa A El-Benhawy3
1Department of Radiography, College of Allied Medical Sciences, Al-Hussein Bin Talal University, Ma'an, Jordan.
Background:
Radiotherapy, a significant cancer treatment, stimulates localized tumor cell death and causes immune modulation. Increasing data has indicated that radiation strengthens tumor-related immunity.
Aim Of The Study:
The aim of this work was to investigate the effect of radiotherapy on soluble forms of the primary immune checkpoints CTLA-4, PD-1 and PD-L1 in patients with breast cancer.
Patients And Methods:
The study was conducted on70 subjects were separated into 2 groups: Group I included 40 patients with breast cancer who received fractionated radiation. Group II: Includes 30 healthy females free from any disease as control group, age and gender matched the patients' group. ELISA was used to assay CTLA-4, PD-1 and PD-L1.
Results:
The current study revealed that soluble PD-1 and PD-L1 are significantly elevated in sera of patients with breast cancer pre radiotherapy treatment and significantly higher than in control group. Exposure to radiotherapy significantly drops PD-1 levels and brings its levels in patients closer to those of healthy individuals but not affects PD-L1 levels. Soluble CTLA-4 is insignificantly elevated in sera of breast cancer patients pre radiotherapy treatment and significantly decreased post radiotherapy.
Conclusion:
Radiotherapy can enhance immune recognition of the tumor cells by dropping the primary immune checkpoints PD-1 and CTLA-4 in breast cancer patients and improve response to immune checkpoints inhibition.
Related Concept Videos
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...